| 10418242 |
Czepita D: [The possibilities of using the newest experimental results in the progressive myopia treatment]. Klin Oczna. 1999;101(2):145-7.
Special attention is focused on the following substances inhibiting the progress of experimental myopia: apomorphine, reserpine, 6-hydroxydopamine, atropine, pirenzepine, chlorpyrifos, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid, kainic acid, naloxane, formoguanamine, gentamicin, sodium iodate, central and peripheral antagonist of vasoactive intestinal polypeptide, basic fibroblast growth factor. |
81(1,1,1,1) |
Details |
| 16519089 |
Czepita D: [Fundamentals of modern treatment of myopia] . Ann Acad Med Stetin. 2005;51(2):5-9.
Additionally, the following substances inhibiting the progress of experimental myopia are discussed: atropine, oxyphenonium, pirenzepine, chlorpyrifos, apomorphine, reserpine, 6-hydroxy dopamine, dextromethorphan, MK-801, APV, bicuculline, SR95531, CACA, TPMPA, dextrorphanol, levorphanol, D- and L-naloxane, L-NAME, formoguanamine, beta-xyloside, central and peripheral antagonists of VIP, and basic fibroblast growth factor. |
81(1,1,1,1) |
Details |